AJP - Renal  AJP: Regulatory, Integrative and Comparative Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 289: F660-F671, 2005; doi:10.1152/ajprenal.00437.2004
0363-6127/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cybulsky, A. V.
Right arrow Articles by Salant, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cybulsky, A. V.
Right arrow Articles by Salant, D. J.

INVITED REVIEW

Experimental membranous nephropathy redux

Andrey V. Cybulsky,1 Richard J. Quigg,2 and David J. Salant3

1Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada; 2Section of Nephrology, The University of Chicago, Chicago, Illinois; and 3Department of Medicine, Evans Biomedical Research Center, Boston University Medical Center, Boston, Massachusetts

Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults. Active and passive Heymann nephritis (HN) in rats are valuable experimental models because their features so closely resemble human MN. In HN, subepithelial immune deposits form in situ as a result of circulating antibodies. Complement activation leads to assembly of C5b-9 on glomerular epithelial cell (GEC) plasma membranes and is essential for sublethal GEC injury and the onset of proteinuria. This review revisits HN and focuses on areas of substantial progress in recent years. The response of the GEC to sublethal C5b-9 attack is not simply due to disruption of the plasma membrane but is due to the activation of specific signaling pathways. These include activation of protein kinases, phospholipases, cyclooxygenases, transcription factors, growth factors, NADPH oxidase, stress proteins, proteinases, and others. Ultimately, these signals impact on cell metabolic pathways and the structure/function of lipids and key proteins in the cytoskeleton and slit-diaphragm. Some signals affect GEC adversely. Thus C5b-9 induces partial dissolution of the actin cytoskeleton. There is a decline in nephrin expression, reduction in F-actin-bound nephrin, and loss of slit-diaphragm integrity. Other signals, such as endoplasmic reticulum stress, may limit complement-induced injury, or promote recovery. The extent of complement activation and GEC injury is dependent, in part, on complement-regulatory proteins, which act at early or late steps within the complement cascade. Identification of key steps in complement activation, the cellular signaling pathways, and the targets will facilitate therapeutic intervention in reversing GEC injury in human MN.

passive Heymann nephritis; podocyte; complement; complement regulation; proteinuria; autoimmunity; cell signaling; cytoskeleton; slit-diaphragm



Address for reprint requests and other correspondence: D. J. Salant, Renal Section, EBRC 504, Boston Univ. Medical Ctr., 650 Albany St., Boston, MA 02118 (e-mail: djsalant{at}bu.edu)




This article has been cited by other articles:


Home page
NEJMHome page
L. H. Beck Jr., R. G.B. Bonegio, G. Lambeau, D. M. Beck, D. W. Powell, T. D. Cummins, J. B. Klein, and D. J. Salant
M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy
N. Engl. J. Med., July 2, 2009; 361(1): 11 - 21.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. W. Pippin, P. T. Brinkkoetter, F. C. Cormack-Aboud, R. V. Durvasula, P. V. Hauser, J. Kowalewska, R. D. Krofft, C. M. Logar, C. B. Marshall, T. Ohse, et al.
Inducible rodent models of acquired podocyte diseases
Am J Physiol Renal Physiol, February 1, 2009; 296(2): F213 - F229.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
P. Ruggenenti, P. Cravedi, M. C. Sghirlanzoni, E. Gagliardini, S. Conti, F. Gaspari, G. Marchetti, M. Abbate, and G. Remuzzi
Effects of Rituximab on Morphofunctional Abnormalities of Membranous Glomerulopathy
Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1652 - 1659.
[Abstract] [Full Text] [PDF]


Home page
Lab AnimHome page
C.-C. Wu, J.-S. Chen, S.-H. Lin, A. Chen, H.-K. Sytwu, and Y.-F. Lin
Experimental model of membranous nephropathy in mice: sequence of histological and biochemical events
Lab Anim, July 1, 2008; 42(3): 350 - 359.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
D. Cohen, J. Papillon, L. Aoudjit, H. Li, A. V. Cybulsky, and T. Takano
Role of calcium-independent phospholipase A2 in complement-mediated glomerular epithelial cell injury
Am J Physiol Renal Physiol, March 1, 2008; 294(3): F469 - F479.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Zhang, A. V. Cybulsky, L. Aoudjit, J. Zhu, H. Li, N. Lamarche-Vane, and T. Takano
Role of Rho-GTPases in complement-mediated glomerular epithelial cell injury
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F148 - F156.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.